Lesion Thickness
Lesion Thickness - Related Videos
09:22
Sectioning Mammary Gland Whole Mounts for Lesion Identification
0 Views •
Cited by 13 •
2017
We developed a method to successfully remove, process, section, and stain, for histopathological evaluation, mammary tissue that had originally been fixed on slides as whole mounts. This method may promote the collection and evaluation of mammary gland whole mounts in reproductive and developmental test guideline studies.
07:59
Murine Full-thickness Skin Transplantation
0 Views •
Cited by 41 •
2017
Murine full-thickness skin transplantation is a well-established model to study rejection in an alloimmune setting. Here, we provide a tutorial of each step involved in performing a BALB/c-->C57BL/6 full-thickness skin transplant.
05:23
Establishment and Evaluation of a Sheep Model of Full-thickness Osteochondral Defect
0 Views •
2026
Here, we present an integrated protocol for generating controlled osteochondral lesions in sheep knees to establish an experimental model suitable for bone and cartilage tissue regeneration studies. The protocol outlines a method for inducing a full-thickness osteochondral defect in the femoral condyle, utilizing techniques that minimize animal welfare impacts and variability in results.
08:17
Organotypic Culture of Full-thickness Adult Porcine Retina
0 Views •
Cited by 19 •
2011
Here we describe a cost-effective technique for organotypic culture of adult porcine retina for seven days. Briefly, a sterile filter paper was used to lift the neural retina off from the RPE and place photoreceptor side up on an insert raised by a custom-made stand.
03:13
Lymphedema Ultrasonography: A Technique to Measure the Change in Thickness of an Affected Tissue
0 Views •
2023
This video utilizes ultrasonography for diagnosis and follow-up tests to determine treatment efficacy of Progressive Resistance Exercise (PRE) in breast cancer-related lymphedema (BCRL). Ultrasonography can be applied effectively to ensure diagnosis and treatment of lymphedema.
FAQs
Thickness has prognostic value because increasing depth reflects more extensive tumor invasion within the skin. In melanoma, a larger measured value generally corresponds to a greater likelihood of regional or distant spread, so it helps clinicians estimate disease severity rather than serving as a purely descriptive pathology measurement. The result therefore influences prognosis and subsequent management discussions.
Reporting the measurement in millimeters creates a standardized numerical result that can be compared across melanoma cases. Pathologists obtain this value through microscopic examination of an excised specimen, allowing clinicians to incorporate a consistent pathology finding into staging and prognosis. Standardized measurement also supports treatment planning and comparison of clinical research results.
Lesion thickness is interpreted together with ulceration rather than in isolation. Ulceration provides an additional pathological finding that contributes to melanoma staging, while thickness supplies the depth-related component of risk assessment. Considering both helps clinicians place the pathology result in the appropriate severity framework and supports decisions about prognosis and further management.
Because it is recorded as a numerical millimeter value, lesion thickness provides a common endpoint for clinical research. Investigators can use the measurement to characterize disease severity and evaluate its relationship to treatment planning and clinical outcomes. Consistent reporting also makes findings from different melanoma cases more readily comparable.
Assessment requires an excised skin lesion specimen that can be examined microscopically by pathology. The examination identifies the lesion’s surface and the deepest point of tumor invasion, allowing the Breslow method to produce a measurement in millimeters. This workflow turns tissue examination into a standardized result that can support staging and prognosis.
Clinicians use the measurement as part of decisions about prognosis, additional surgery, and lymph node evaluation. A greater value generally signals higher risk and may prompt more intensive consideration of these management questions. The result does not stand alone; it contributes to planning alongside other pathological findings, including ulceration.
Lesion thickness helps estimate melanoma severity and the likelihood of regional or distant spread, but it is not the complete staging assessment. Ulceration and other relevant pathology findings also contribute to staging. Consequently, the measurement provides an important risk-related component for clinical interpretation rather than a standalone description of the entire disease.